Iradimed Corp. (IRMD) Tops Q2 EPS by 5c

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $5.5 million versus the consensus estimate of $5.41 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance